Answer
Systemic ketoconazole significantly increases systemic exposure to salmeterol in Seretide Accuhaler, potentially increasing palpitations and QTc prolongation; concomitant treatment should be avoided unless benefits outweigh the potentially increased risk of systemic salmeterol side effects.
Sources for this answer
- Seretide 100, 250, 500 AccuhalerGlaxoSmithKline UK · emc · SmPC §4.4 Special warnings and precautions for use · Version 46Document updated
Sources checked